BBC holdings

All 125 positions of Virtus Biotech Clinical Trials ETF.

Download CSV

Positions

125

Top 10 weight

16.2%

Effective holdings

104.1

1 / sum of squared weights

In stocks

99.9%

In bonds

0.0%

Outside the US

15.9%

Asset mix

Equity99.9%
Cash2.3%

Sectors

93% of stocks classified

Health Care92.6%
Technology0.6%

Countries

United States84.1%
Canada4.4%
Netherlands3.1%
Cayman Islands2.9%
United Kingdom2.7%
Ireland2.0%
British Virgin Islands0.6%
Singapore0.3%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	DREYFUS GOVERNMENT CASH MANAGE	Cash	2.28%	$852K	852,188	US
2	ERASErasca, Inc. Common Stock	Equity	2.19%	$817K	76,668	US
3	ELVNEnliven Therapeutics, Inc. Common Stock	Equity	1.81%	$675K	16,370	US
4	TNGXTango Therapeutics, Inc.	Equity	1.71%	$638K	29,518	US
5	ORKAOruka Therapeutics, Inc. Common Stock	Equity	1.68%	$625K	9,143	US
6	SYRESpyre Therapeutics, Inc. Common Stock	Equity	1.64%	$611K	8,208	US
7	ALMSAlumis Inc. Common Stock	Equity	1.59%	$593K	24,020	US
8	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	1.54%	$575K	6,551	US
9	KODKodiak Sciences Inc Common Stock	Equity	1.35%	$504K	11,591	US
10	RVMDRevolution Medicines, Inc. Common Stock	Equity	1.35%	$504K	3,496	US
11	CRVSCorvus Pharmaceuticals, Inc.	Equity	1.34%	$501K	32,976	US
12	RZLTRezolute, Inc. Common Stock (NV)	Equity	1.31%	$491K	153,338	US
13	DFTXDefinium Therapeutics, Inc. Common Shares	Equity	1.29%	$481K	21,993	CA
14	CGONCG Oncology, Inc. Common stock	Equity	1.21%	$450K	6,741	US
15	JBIOJade Biosciences, Inc. Common Stock	Equity	1.20%	$450K	18,425	US
16	INBXInhibrx Biosciences, Inc. Common Stock	Equity	1.20%	$448K	3,467	US
17	RLAYRelay Therapeutics, Inc. Common Stock	Equity	1.19%	$445K	34,371	US
18	GH RESEARCH PLC	Equity	1.16%	$435K	21,175	IE
19	NKTRNektar Therapeutics	Equity	1.15%	$429K	5,045	US
20	TYRATyra Biosciences, Inc. Common Stock	Equity	1.14%	$424K	12,196	US
21	VIRVir Biotechnology, Inc. Common Stock	Equity	1.13%	$421K	41,256	US
22	NTLAIntellia Therapeutics, Inc	Equity	1.10%	$412K	30,599	US
23	CNTACentessa Pharmaceuticals plc American Depositary Shares	Equity	1.10%	$410K	10,411	GB
24	ANABAnaptysBio, Inc. Common Stock	Equity	1.08%	$404K	6,139	US
25	OMEROmeros Corporation	Equity	1.06%	$397K	27,192	US
26	TECXTectonic Therapeutic, Inc. Common Stock	Equity	1.05%	$391K	13,966	US
27	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	1.04%	$389K	182,788	US
28	CMPSCOMPASS Pathways Plc American Depository Shares	Equity	0.99%	$371K	40,950	GB
29	EWTXEdgewise Therapeutics, Inc. Common Stock	Equity	0.97%	$362K	11,685	US
30	PVLAPalvella Therapeutics, Inc. Common Stock	Equity	0.96%	$359K	2,798	US
31	CAPRCapricor Therapeutics Inc	Equity	0.95%	$356K	10,606	US
32	PCVXVaxcyte, Inc. Common Stock	Equity	0.95%	$355K	6,201	US
33	PHARVARIS NV	Equity	0.95%	$354K	11,424	NL
34	AVBPArriVent BioPharma, Inc. Common Stock	Equity	0.94%	$351K	11,300	US
35	XENEXenon Pharmaceuticals Inc	Equity	0.94%	$351K	6,264	CA
36	NGNENeurogene, Inc. Common Stock	Equity	0.92%	$344K	13,193	US
37	SMMTSummit Therapeutics Inc. Common Stock	Equity	0.90%	$337K	15,708	US
38	AMLXAmylyx Pharmaceuticals, Inc. Common Stock	Equity	0.90%	$337K	21,068	US
39	CLDXCelldex Therapeutics, Inc	Equity	0.88%	$330K	10,032	US
40	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	0.88%	$327K	1,026	US
41	RCUSArcus Biosciences, Inc.	Equity	0.88%	$327K	12,819	US
42	ANNXAnnexon, Inc. Common Stock	Equity	0.87%	$326K	55,535	US
43	TERNTerns Pharmaceuticals, Inc. Common Stock	Equity	0.87%	$325K	6,132	US
44	LQDALiquidia Corporation Common Stock	Equity	0.87%	$324K	8,268	US
45	GLUEMonte Rosa Therapeutics, Inc. Common Stock	Equity	0.87%	$324K	16,922	US
46	IMNMImmunome, Inc.	Equity	0.87%	$323K	14,102	US
47	BCAXBicara Therapeutics Inc. Common Stock	Equity	0.86%	$322K	14,934	US
48	CELCCelcuity Inc. Common Stock	Equity	0.85%	$318K	2,621	US
49	IRWDIronwood Pharmaceuticals, Inc. - Class A	Equity	0.85%	$318K	77,097	US
50	ABCLAbCellera Biologics Inc. Common Shares	Equity	0.85%	$316K	76,245	CA
51	PGENPrecigen, Inc. Common Stock	Equity	0.83%	$311K	74,799	US
52	BLTEBelite Bio, Inc American Depositary Shares	Equity	0.83%	$311K	1,952	KY
53	BEAMBeam Therapeutics Inc. Common Stock	Equity	0.82%	$306K	10,087	US
54	MLTXMoonLake Immunotherapeutics Class A Ordinary Shares	Equity	0.82%	$306K	18,661	KY
55	TSHATaysha Gene Therapies, Inc. Common Stock	Equity	0.82%	$305K	47,669	US
56	CGEMCullinan Therapeutics, Inc. Common Stock	Equity	0.81%	$302K	23,153	US
57	IMMATICS NV	Equity	0.81%	$302K	27,490	NL
58	RAPPRapport Therapeutics, Inc. Common Stock	Equity	0.81%	$302K	9,118	US
59	ZYMEZymeworks Inc.	Equity	0.80%	$298K	10,832	US
60	APGEApogee Therapeutics, Inc. Common Stock	Equity	0.79%	$297K	3,580	US
61	PROTHENA CORP PLC	Equity	0.79%	$295K	26,642	IE
62	ORICOric Pharmaceuticals, Inc. Common Stock	Equity	0.78%	$291K	29,424	US
63	DNLIDenali Therapeutics Inc. Common Stock	Equity	0.77%	$287K	15,351	US
64	PTGXProtagonist Therapeutics, Inc	Equity	0.77%	$286K	2,894	US
65	MEIRAGTX HOLDINGS PLC	Equity	0.76%	$285K	30,942	KY
66	IMVTImmunovant, Inc. Common Stock	Equity	0.76%	$284K	10,446	US
67	RCKTRocket Pharmaceuticals, Inc. Common Stock	Equity	0.76%	$283K	81,418	US
68	UNIQURE NV	Equity	0.76%	$282K	14,147	NL
69	SLNOSoleno Therapeutics, Inc. Common Stock	Equity	0.75%	$280K	5,306	US
70	MBXMBX Biosciences, Inc. Common Stock	Equity	0.75%	$279K	9,242	US
71	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.75%	$279K	8,521	US
72	CYTKCytokinetics Inc.	Equity	0.75%	$279K	4,355	US
73	CTMXCytomX Therapeutics, Inc.	Equity	0.74%	$278K	65,872	US
74	SRRKScholar Rock Holding Corporation Common Stock	Equity	0.74%	$274K	5,888	US
75	ATAIAtaiBeckley Inc. Common Stock	Equity	0.72%	$268K	64,337	US
76	NUVLNuvalent, Inc. Class A Common Stock	Equity	0.71%	$264K	2,633	US
77	JANXJanux Therapeutics, Inc. Common Stock	Equity	0.69%	$259K	18,038	US
78	SEPNSepterna, Inc. Common Stock	Equity	0.69%	$258K	10,849	US
79	DYNDyne Therapeutics, Inc. Common Stock	Equity	0.67%	$251K	14,322	US
80	SIONSionna Therapeutics, Inc. Common Stock	Equity	0.67%	$250K	6,453	US
81	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.67%	$249K	3,077	US
82	ABUSArbutus Biopharma Corporation Common Stock	Equity	0.66%	$246K	58,600	CA
83	NRIXNurix Therapeutics, Inc. Common stock	Equity	0.65%	$242K	14,473	US
84	PRMEPrime Medicine, Inc. Common Stock	Equity	0.64%	$239K	67,319	US
85	PROKProKidney Corp. Class A Ordinary Shares	Equity	0.64%	$237K	124,892	US
86	ENGNenGene Therapeutics Inc. Common Stock	Equity	0.64%	$237K	32,625	CA
87	IDYAIDEAYA Biosciences, Inc. Common Stock	Equity	0.63%	$236K	8,112	US
88	XERSXeris Biopharma Holdings, Inc. Common Stock	Equity	0.63%	$236K	38,494	US
89	COGTCogent Biosciences, Inc. Common Stock	Equity	0.63%	$235K	6,554	US
90	VKTXViking Therapeutics, Inc	Equity	0.62%	$232K	7,443	US
91	BIOHAVEN LTD	Equity	0.61%	$230K	23,938	VG
92	EYPTEyePoint, Inc. Common Stock	Equity	0.61%	$228K	17,260	US
93	FDMT4D Molecular Therapeutics, Inc. Common Stock	Equity	0.60%	$226K	25,461	US
94	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	0.59%	$221K	63,742	US
95	ARVNArvinas, Inc	Equity	0.58%	$217K	21,940	US
96	NEWAMSTERDAM PHARMA COMPANY NV	Equity	0.57%	$212K	7,408	NL
97	SVRASavara Inc.	Equity	0.56%	$209K	39,885	US
98	ASMBAssembly Biosciences, Inc	Equity	0.55%	$206K	7,645	US
99	XNCRXencor, Inc.	Equity	0.53%	$199K	16,707	US
100	MLYSMineralys Therapeutics, Inc. Common Stock	Equity	0.53%	$199K	7,478	US
101	IRONDisc Medicine, Inc. Common Stock	Equity	0.53%	$198K	3,004	US
102	VERAVera Therapeutics, Inc. Class A Common Stock	Equity	0.53%	$197K	5,541	US
103	RIGLRigel Pharmaceuticals Inc. (New)	Equity	0.52%	$196K	6,766	US
104	MNPRMonopar Therapeutics Inc. Common Stock	Equity	0.52%	$193K	3,699	US
105	MAZEMaze Therapeutics, Inc. Common Stock	Equity	0.51%	$189K	7,102	US
106	RGNXREGENXBIO Inc.	Equity	0.48%	$179K	19,900	US
107	SANASana Biotechnology, Inc. Common Stock	Equity	0.47%	$177K	53,698	US
108	BCYCBicycle Therapeutics plc American Depositary Shares	Equity	0.47%	$175K	37,047	GB
109	GPCRStructure Therapeutics Inc. American Depositary Shares	Equity	0.46%	$171K	4,115	KY
110	IVVDInvivyd, Inc. Common Stock	Equity	0.45%	$167K	118,970	US
111	LXEOLexeo Therapeutics, Inc. Common Stock	Equity	0.43%	$161K	28,249	US
112	VSTMVerastem, Inc.	Equity	0.42%	$157K	28,720	US
113	FULCFulcrum Therapeutics, Inc. Common Stock	Equity	0.41%	$151K	21,230	US
114	TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares	Equity	0.38%	$143K	6,139	US
115	KROSKeros Therapeutics, Inc. Common Stock	Equity	0.38%	$143K	12,830	US
116	ALTAltimmune, Inc. Common Stock	Equity	0.36%	$136K	52,374	US
117	ZBIOZenas BioPharma, Inc. Common Stock	Equity	0.35%	$131K	6,799	US
118	OLMAOlema Pharmaceuticals, Inc. Common Stock	Equity	0.32%	$120K	8,351	US
119	WAVE LIFE SCIENCES LTD	Equity	0.32%	$118K	16,665	SG
120	VRDNViridian Therapeutics, Inc. Common Stock	Equity	0.31%	$115K	8,542	US
121	CMPXCompass Therapeutics, Inc. Common Stock	Equity	0.25%	$95K	53,489	US
122	UPBUpstream Bio, Inc. Common Stock	Equity	0.25%	$93K	10,169	US
123	REPLReplimune Group, Inc.	Equity	0.19%	$70K	27,112	US
124	MREOMereo BioPharma Group plc American Depositary Shares	Equity	0.09%	$34K	127,193	GB
125	GOSSGossamer Bio, Inc. Common Stock	Equity	0.08%	$28K	76,668	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	VTYXVentyx Biosciences Inc	1.31%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	RAPTRAPT Therapeutics Inc	1.20%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	ENGNWEngene Holdings Inc	0.86%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	ACLXArcellx Inc	0.73%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
New position	ENGNENGENE THERAPEUTICS INC	—	0.64%	—	Jan 30, 2026 → Apr 30, 2026 SEC
New position	TRAXFIRST TRACKS BIOTHERAPEUTICS INC	—	0.38%	—	Jan 30, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.